Abstract
The aim of this study was to investigate the therapeutic efficacy of the alpha-radioimmunotherapy of ovarian cancer in mice, using different specific activities. This study was performed by using the monoclonal antibody, MX35 F(ab')(2), labeled with the alpha-particle-emitter, 211At.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Cancer Biotherapy & Radiopharmaceuticals |
Vol/bind | 24 |
Udgave nummer | 4 |
Sider (fra-til) | 509-13 |
Antal sider | 5 |
ISSN | 1084-9785 |
DOI | |
Status | Udgivet - 1 aug. 2009 |